國際醫學(000516.SZ)：商洛國際醫學中心醫院新院區昨日正式開診
格隆匯3月29日丨國際醫學(000516.SZ)宣佈，公司醫療服務主業佈局重大項目——商洛國際醫學中心醫院新院區已於2021年3月28日正式開診。
商洛國際醫學中心醫院是公司繼西安高新醫院、西安國際醫學中心醫院之後，以共享國際醫學優質資源，同步世界先進診療水平的理念，按三級甲等醫院標準重點建設的服務陝南地區患者的大型現代化區域性醫療中心。醫院建築面積22萬平方米，規劃牀位1800張。
醫院學科全面，設有神經內科、神經外科、腫瘤科、心血管內科、心胸外科、消化內科、骨科、眼科、產科、肛腸科、兒科、耳鼻喉科、重症醫學科、微創介入科等41個臨牀科室，醫學影像科、核醫學科、放射治療、高壓氧艙等10個醫技科室。
新醫院設備精良，全國領先，配備有730醫用血管造影機、PET-CT、3.0TMRI、256排CT、DSA、DR、B超、直線加速器、大孔徑CT、移動C型臂X線機、電子胃腸鏡、體外衝擊波碎石機、經顱多譜勒超聲診斷儀(TCD)、全自動生化分析儀、血液透析機、Leep刀、白內障超聲乳化儀、532眼底激光機、眼底熒光造影機、耳鼻喉內窺鏡系統、電子鼻咽喉鏡、多導睡眠監測系統等多部西北首台、商洛首台的大型醫療設備。
公司表示，商洛國際醫學中心醫院新院區作為公司目前在外埠投資運營的第一家按三級甲等標準建設的大型綜合性醫院，也是公司積極構建跨區域醫療服務連鎖發展網絡的省市重點項目、商洛重大民生工程。經過多年運營，商洛國際醫學中心醫院老院區在當地醫療市場已具有較高的知名度和影響力，在公司有力支持下，隨着商洛國際醫學中心醫院新院區正式啟用、開診，將為該醫院就醫環境、醫療服務水平帶來全面提升，並大幅增強該院在所在區域的市場競爭力。
未來，公司將全面整合旗下各醫院人才、教學、設備等醫療資源，推進資源共享、高效協同發展，通過集團內優質醫療資源下沉，有效緩解區域內優質醫療資源供應緊張狀況，方便羣眾就診。該院新院區的開診預計將對公司未來業績增長產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
